National Cancer InstituteU.S. National Institutes of Health | www.cancer.gov
U.S. National Institutes of Health www.cancer.gov

Home | About ICSN | Collaborative Projects | Meetings | Cancer Sites | Publications | Contact Us
Cervical Cancer (Archived Tables): Home

Organization of Cervical Cancer Screening Programs in 20 ICSN Countries, 2007-2008

Region/Country Program Type1 Year Program Began Detection Methods2 AgeGroups Covered Recommended Interval for average risk (under 70)
Australia NS 1991 PC 20-69 2 years
Brazil N 1985 PC 25-59 3 years
Canada S   PLC, PC 15-69 Varies by prov.
Denmark NS 1962 PLC, PC 20-59 3 years
Finland N 1963 PC 30-59 5 years
France S 1990 PC 25-69 3 years
Germany O 1971 PC 20-70+ 1 year
Hungary N 2003 PC 25-59 3 years
Iceland N 1964 PC 20-69 2-3 years
Italy NS 1996 PLC, PC, HPV-T 25-69 3 years
Ireland P 2000 PLC 25-69 3 years (25-44); 5 years (45-60)
Japan NS 1983 PC 20-70+ 2 years
Korea N 2002 PC 30-70+ 2 years
Netherlands N 1989 PLC, PC 30-69 5 years
New Zealand N 1990 PLC, PC 20-69 3 years
Norway N 1995 PC, HPV-T 20-69 3 years
Sweden NS 1969 PC, HPV-T 25-59 3 years
United Kingdom N 1987 PLC, PC 25-69 3 years (35-49); 5 years (50-64)
United States O 1991 PLC, PC, HPV-T 40-70+ 3 years
Uruguay S 1994 PLC, PC 30-69 3 years

1 Program Types:

N (National screening policy with national program implementation)
NS (National screening policy with state/provincial/regional screening program implementation)
S (State/Provincial/Regional screening and program implementation)
P (pilot program)
O (Other)

2 Detection Methods:

PLC (Pap test, liquid-based cytology)
PC (Pap test, liquid-based cytology)
HPV-T (HPV test triage)
HPV-P (HPV test primary screening)